Understanding extranuclear (nongenomic) androgen signaling: What a frog oocyte can tell us about human biology

Steroids

Volumn 76, Issue 9, 2011, Pages 822-828

  Sen, Aritro ^a   Prizant, Hen ^a   Hammes, Stephen R ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Androgen; Extranuclear; Kinase; Nongenomic; Paxillin

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; CYCLIN DEPENDENT KINASE 1; EPIDERMAL GROWTH FACTOR RECEPTOR; FOCAL ADHESION KINASE; GONADOTROPIN; GUANINE NUCLEOTIDE BINDING PROTEIN; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; PAXILLIN; PROGESTERONE; PROSTATE SPECIFIC ANTIGEN; STEROID RECEPTOR; TESTOSTERONE;

BONE DEVELOPMENT; BONE TURNOVER; CANCER CELL; CELL FUNCTION; CELL MATURATION; CELL MEMBRANE; CELL PROLIFERATION; ENZYME ACTIVATION; EXTRANUCLEAR ANDROGEN SIGNALING; HORMONE RESPONSE; IMMUNE RESPONSE; IMMUNE SYSTEM; INTRANUCLEAR SPACE; MUSCLE DEVELOPMENT; NONGENOMIC ANDROGEN SIGNALING; NONHUMAN; OOCYTE; OOCYTE MATURATION; PROSTATE CANCER; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; SPERMATOGENESIS; TRANSACTIVATION; XENOPUS LAEVIS;

ANDROGENS; ANIMALS; BONE AND BONES; FEMALE; HUMANS; IMMUNE SYSTEM; MALE; MUSCLE, SKELETAL; OOCYTES; OVULATION; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; XENOPUS LAEVIS;

ANURA; MAMMALIA; XENOPUS LAEVIS;

EID: 79959913355     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2011.02.016     Document Type: Review

References (114)

1. Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 1995;16(3):271-321.
2. Hu YC, Wang PH, Yeh S, Wang RS, Xie C, Xu Q, et al. Subfertility and defective folliculogenesis in female mice lacking androgen receptor. Proc Natl Acad Sci USA 2004;101(31):11209-14. (Pubitemid 39038327)
3. Shiina H, Matsumoto T, Sato T, Igarashi K, Miyamoto J, Takemasa S, et al. Premature ovarian failure in androgen receptor-deficient mice. Proc Natl Acad Sci USA 2006;103(1):224-9. (Pubitemid 43076131)
4. Sen A, Hammes SR. Granulosa cell-specific androgen receptors are critical regulators of ovarian development and function. Mol Endocrinol 2010;24(7):1393-403.
5. Marker PC, Donjacour AA, Dahiya R, Cunha GR. Hormonal, cellular, and molecular control of prostatic development. Dev Biol 2003;253(2):165-74. (Pubitemid 36259879)
6. Hayward SW, Cunha GR. The prostate: development and physiology. Radiol Clin North Am 2000;38(1):1-14. (Pubitemid 30059002)
7. Xu Y, Chen SY, Ross KN, Balk SP. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins. Cancer Res 2006;66(15):7783-92. (Pubitemid 44289239)
8. Lange CA, Gioeli D, Hammes SR, Marker PC. Integration of rapid signaling events with steroid hormone receptor action in breast and prostate cancer. Annu Rev Physiol 2007;69:171-99. (Pubitemid 46457640)
9. Manolagas SC, Kousteni S, Jilka RL. Sex steroids and bone. Recent Prog Horm Res 2002;57:385-409.
10. Hammes SR, Levin ER. Extranuclear steroid receptors: nature and actions. Endocr Rev 2007;28(7):726-41. (Pubitemid 350294293)
11. Hammes SR. The further redefining of steroid-mediated signaling. Proc Natl Acad Sci USA 2003;100(5):2168-70. (Pubitemid 36297469)
12. Hammes SR. Steroids and oocyte maturation: a new look at an old story. Mol Endocrinol 2004;18(4):769-75. (Pubitemid 38429471)
13. Albertini DF, Carabatsos MJ. Comparative aspects of meiotic cell cycle control in mammals. J Mol Med 1998;76(12):795-9. (Pubitemid 28518704)
14. Albertini DF, Combelles CM, Benecchi E, Carabatsos MJ. Cellular basis for paracrine regulation of ovarian follicle development. Reproduction 2001;121(5):647-53. (Pubitemid 32472050)
15. Deng J, Carbajal L, Evaul K, Rasar M, Jamnongjit M, Hammes SR. Nongenomic steroid-triggered oocyte maturation: of mice and frogs. Steroids 2009;74(7):595-601.
16. Maller JL, Krebs EG. Regulation of oocyte maturation. Curr Top Cell Regul 1980;16:271-311.
17. Smith LD, Ecker RE. The interaction of steroids with Rana pipiens oocytes in the induction of maturation. Dev Biol 1971;25(2):232-47.
18. Newport JW, Kirschner MW. Regulation of the cell cycle during early Xenopus development. Cell 1984;37(3):731-42. (Pubitemid 15139273)
19. Tian J, Kim S, Heilig E, Ruderman JV. Identification of XPR-1, a progesterone receptor required for Xenopus oocyte activation. Proc Natl Acad Sci USA 2000;97(26):14358-63. (Pubitemid 32016580)
20. Bayaa M, Booth RA, Sheng Y, Liu XJ. The classical progesterone receptor mediates Xenopus oocyte maturation through a nongenomic mechanism. Proc Natl Acad Sci USA 2000;97(23):12607-12.
21. Lutz LB, Cole LM, Gupta MK, Kwist KW, Auchus RJ, Hammes SR. Evidence that androgens are the primary steroids produced by Xenopus laevis ovaries and may signal through the classical androgen receptor to promote oocyte maturation. Proc Natl Acad Sci USA 2001;98(24):13728-33. (Pubitemid 33115966)
22. Yang WH, Lutz LB, Hammes SR. Xenopus laevis ovarian CYP17 is a highly potent enzyme expressed exclusively in oocytes evidence that oocytes play a critical role in Xenopus ovarian androgen production. J Biol Chem 2003;278(11):9552-9. (Pubitemid 36800449)
23. White SN, Jamnongjit M, Gill A, Lutz LB, Hammes SR. Specific modulation of nongenomic androgen signaling in the ovary. Steroids 2005;70(5-7):352-60. (Pubitemid 40616032)
24. Lutz LB, Jamnongjit M, Yang WH, Jahani D, Gill A, Hammes SR. Selective modulation of genomic and nongenomic androgen responses by androgen receptor ligands. Mol Endocrinol 2003;17(6):1106-16. (Pubitemid 36683718)
25. Gallo CJ, Hand AR, Jones TL, Jaffe LA. Stimulation of Xenopus oocyte maturation by inhibition of the G-protein alpha S subunit, a component of the plasma membrane and yolk platelet membranes. J Cell Biol 1995;130(2):275-84.
26. Evaul K, Jamnongjit M, Bhagavath B, Hammes SR. Testosterone and progesterone rapidly attenuate plasma membrane Gbetagamma-mediated signaling in Xenopus laevis oocytes by signaling through classical steroid receptors. Mol Endocrinol 2007;21(1):186-96. (Pubitemid 46041699)
27. Lutz LB, Kim B, Jahani D, Hammes SR. G protein beta gamma subunits inhibit nongenomic progesterone-induced signaling and maturation in Xenopus laevis oocytes evidence for a release of inhibition mechanism for cell cycle progression. J Biol Chem 2000;275(52):41512-20. (Pubitemid 32054988)
28. Sheng Y, Montplaisir V, Liu XJ. Co-operation of Gsalpha and Gbetagamma in maintaining G2 arrest in Xenopus oocytes. J Cell Physiol 2005;202(1):32-40.
29. Ferrell Jr JE, Machleder EM. The biochemical basis of an all-or-none cell fate switch in Xenopus oocytes. Science 1998;280(5365):895-8. (Pubitemid 28215598)
30. Guadagno TM, Ferrell Jr JE. Requirement for MAPK activation for normal mitotic progression in Xenopus egg extracts. Science 1998;282(5392):1312-5. (Pubitemid 28524492)
31. Deng J, Lang S, Wylie C, Hammes SR. The Xenopus laevis isoform of G protein-coupled receptor 3 (GPR3) is a constitutively active cell surface receptor that participates in maintaining meiotic arrest in X. laevis oocytes. Mol Endocrinol 2008;22(8):1853-65.
32. Sheng Y, Tiberi M, Booth RA, Ma C, Liu XJ. Regulation of Xenopus oocyte meiosis arrest by G protein betagamma subunits. Curr Biol 2001;11(6):405-16. (Pubitemid 32241518)
33. Sadler SE, Maller JL. Progesterone inhibits adenylate cyclase in Xenopus oocytes action on the guanine nucleotide regulatory protein. J Biol Chem 1981;256(12):6368-73. (Pubitemid 11058067)
34. Conti M, Andersen CB, Richard F, Mehats C, Chun SY, Horner K, et al. Role of cyclic nucleotide signaling in oocyte maturation. Mol Cell Endocrinol 2002;187(1-2):153-9. (Pubitemid 34436944)
35. Haas D, White SN, Lutz LB, Rasar M, Hammes SR. The modulator of nongenomic actions of the estrogen receptor (MNAR) regulates transcription-independent androgen receptor-mediated signaling: evidence that MNAR participates in G protein-regulated meiosis in Xenopus laevis oocytes. Mol Endocrinol 2005;19(8):2035-46. (Pubitemid 41124199)
36. Vadlamudi RK, Kumar R. Functional and biological properties of the nuclear receptor coregulator PELP1/MNAR. Nucl Recept Signal 2007;5:e004.
37. Gebauer F, Xu W, Cooper GM, Richter JD. Translational control by cytoplasmic polyadenylation of c-mos mRNA is necessary for oocyte maturation in the mouse. EMBO J 1994;13(23):5712-20. (Pubitemid 24363039)
38. Stebbins-Boaz B, Hake LE, Richter JD. CPEB controls the cytoplasmic polyadenylation of cyclin, Cdk2 and c-mos mRNAs and is necessary for oocyte maturation in Xenopus. EMBO J 1996;15(10):2582-92.
39. de Moor CH, Richter JD. The Mos pathway regulates cytoplasmic polyadenylation in Xenopus oocytes. Mol Cell Biol 1997;17(11):6419-26. (Pubitemid 27451187)
40. Mendez R, Hake LE, Andresson T, Littlepage LE, Ruderman JV, Richter JD. Phosphorylation of CPE binding factor by Eg2 regulates translation of c-mos mRNA. Nature 2000;404(6775):302-7. (Pubitemid 30163550)
41. Martinez SE, Yuan L, Lacza C, Ransom H, Mahon GM, Whitehead IP, et al. XGef mediates early CPEB phosphorylation during Xenopus oocyte meiotic maturation. Mol Biol Cell 2005;16(3):1152-64. (Pubitemid 40349553)
42. Resing KA, Mansour SJ, Hermann AS, Johnson RS, Candia JM, Fukasawa K, et al. Determination of v-Mos-catalyzed phosphorylation sites and autophosphorylation sites on MAP kinase kinase by ESI/MS. Biochemistry 1995;34(8):2610-20.
43. Rasar M, DeFranco DB, Hammes SR. Paxillin regulates steroid-triggered meiotic resumption in oocytes by enhancing an all-or-none positive feedback kinase loop. J Biol Chem 2006;281(51):39455-64. (Pubitemid 46041905)
44. Brown MC, Turner CE. Paxillin: adapting to change. Physiol Rev 2004;84(4):1315-39. (Pubitemid 39287952)
45. Rasar MA, Hammes SR. The physiology of the Xenopus laevis ovary. Methods Mol Biol 2006;322:17-30.
46. Gotoh Y, Masuyama N, Dell K, Shirakabe K, Nishida E. Initiation of Xenopus oocyte maturation by activation of the mitogen-activated protein kinase cascade. J Biol Chem 1995;270(43):25898-904.
47. Matten WT, Copeland TD, Ahn NG, Vande Woude GF. Positive feedback between MAP kinase and Mos during Xenopus oocyte maturation. Dev Biol 1996;179(2):485-92. (Pubitemid 26384091)
48. Roy LM, Haccard O, Izumi T, Lattes BG, Lewellyn AL, Maller JL. Mos proto-oncogene function during oocyte maturation in Xenopus. Oncogene 1996;12(10):2203-11. (Pubitemid 26168429)
49. Gill A, Jamnongjit M, Hammes SR. Androgens promote maturation and signaling in mouse oocytes independent of transcription: a release of inhibition model for mammalian oocyte meiosis. Mol Endocrinol 2004;18(1):97-104. (Pubitemid 38073157)
50. Li M, Ai JS, Xu BZ, Xiong B, Yin S, Lin SL, et al. Testosterone potentially triggers meiotic resumption by activation of intra-oocyte SRC and MAPK in porcine oocytes. Biol Reprod 2008;79(5):897-905.
51. Li M, Schatten H, Sun QY. Androgen receptor's destiny in mammalian oocytes: a new hypothesis. Mol Hum Reprod 2009;15(3):149-54.
52. Neill JD. In: Challis JRG, Kretser DM, Pfaff DW, Richards JS, Plant TM, Wassarman PM, editors. Knobil and Neill's physiology of reproduction, vol. 1, 3rd ed. Elsevier Academic Press; 2006.
53. McLachlan RI, O'Donnell L, Meachem SJ, Stanton PG, de Kretser DM, Pratis K, et al. Identification of specific sites of hormonal regulation in spermatogenesis in rats, monkeys, and man. Recent Prog Horm Res 2002;57:149-79.
54. Lyon MF, Glenister PH, Lamoreux ML. Normal spermatozoa from androgen-resistant germ cells of chimaeric mice and the role of androgen in spermatogenesis. Nature 1975;258(5536):620-2.
55. Griswold MD. The central role of Sertoli cells in spermatogenesis. Semin Cell Dev Biol 1998;9(4):411-6. (Pubitemid 128350667)
56. Walker WH. Molecular mechanisms of testosterone action in spermatogenesis. Steroids 2009;74(7):602-7.
57. Eacker SM, Shima JE, Connolly CM, Sharma M, Holdcraft RW, Griswold MD, et al. Transcriptional profiling of androgen receptor (AR) mutants suggests instructive and permissive roles of AR signaling in germ cell development. Mol Endocrinol 2007;21(4):895-907. (Pubitemid 46984730)
58. Lindsey JS, Wilkinson MF. Pem: a testosterone- and LH-regulated homeobox gene expressed in mouse Sertoli cells and epididymis. Dev Biol 1996;179(2):471-84. (Pubitemid 26384090)
59. Lim K, Yoo JH, Kim KY, Kweon GR, Kwak ST, Hwang BD. Testosterone regulation of proto-oncogene c-myc expression in primary Sertoli cell cultures from prepubertal rats. J Androl 1994;15(6):543-50.
60. Walker WH. Molecular mechanisms controlling Sertoli cell proliferation and differentiation. Endocrinology 2003;144(9):3719-21. (Pubitemid 37088721)
61. Shang Y, Myers M, Brown M. Formation of the androgen receptor transcription complex. Mol Cell 2002;9(3):601-10. (Pubitemid 34273790)
62. Fix C, Jordan C, Cano P, Walker WH. Testosterone activates mitogen-activated protein kinase and the cAMP response element binding protein transcription factor in Sertoli cells. Proc Natl Acad Sci USA 2004;101(30):10919-24. (Pubitemid 38989560)
63. Pedram A, Razandi M, Sainson RC, Kim JK, Hughes CC, Levin ER. A conserved mechanism for steroid receptor translocation to the plasma membrane. J Biol Chem 2007;282(31):22278-88. (Pubitemid 47267344)
64. Lu ML, Schneider MC, Zheng Y, Zhang X, Richie JP. Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J Biol Chem 2001;276(16):13442-51.
65. Walker WH, Cheng J. FSH and testosterone signaling in Sertoli cells. Reproduction 2005;130(1):15-28. (Pubitemid 41015229)
66. Walker WH. Nongenomic actions of androgen in Sertoli cells. Curr Top Dev Biol 2003;56:25-53. (Pubitemid 137639482)
67. Cheng J, Watkins SC, Walker WH. Testosterone activates mitogen-activated protein kinase via Src kinase and the epidermal growth factor receptor in sertoli cells. Endocrinology 2007;148(5):2066-74. (Pubitemid 46997076)
68. Scobey M, Bertera S, Somers J, Watkins S, Zeleznik A, Walker W. Delivery of a cyclic adenosine 3′,5′-monophosphate response element-binding protein (creb) mutant to seminiferous tubules results in impaired spermatogenesis. Endocrinology 2001;142(2):948-54. (Pubitemid 32222445)
69. Lyng FM, Jones GR, Rommerts FF. Rapid androgen actions on calcium signaling in rat sertoli cells and two human prostatic cell lines: similar biphasic responses between 1 picomolar and 100 nanomolar concentrations. Biol Reprod 2000;63(3):736-47. (Pubitemid 30659267)
70. Loss ES, Jacobsen M, Costa ZS, Jacobus AP, Borelli F, Wassermann GF. Testosterone modulates K(+)ATP channels in Sertoli cell membrane via the PLC-PIP2 pathway. Horm Metab Res 2004;36(8):519-25. (Pubitemid 39233522)
71. Gorczynska E, Handelsman DJ. Androgens rapidly increase the cytosolic calcium concentration in Sertoli cells. Endocrinology 1995;136(5):2052-9.
72. Radmayr C, Lunacek A, Schwentner C, Oswald J, Klocker H, Bartsch G. 5-alpha-reductase and the development of the human prostate. Indian J Urol 2008;24(3):309-12.
73. Carson 3rd C, Rittmaster R. The role of dihydrotestosterone in benign prostatic hyperplasia. Urology 2003;61:2-7 (4 Suppl. 1).
74. Berger R, Febbo PG, Majumder PK, Zhao JJ, Mukherjee S, Signoretti S, et al. Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells. Cancer Res 2004;64(24):8867-75. (Pubitemid 39665491)
75. Gioeli D, Ficarro SB, Kwiek JJ, Aaronson D, Hancock M, Catling AD, et al. Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites. J Biol Chem 2002;277(32):29304-14.
76. Foradori CD, Weiser MJ, Handa RJ. Non-genomic actions of androgens. Front Neuroendocrinol 2008;29(2):169-81.
77. Taplin ME, Balk SP. Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence. J Cell Biochem 2004;91(3):483-90.
78. Watson PA, Chen YF, Balbas MD, Wongvipat J, Socci ND, Viale A, et al. Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor. Proc Natl Acad Sci USA 2010;107(39):16759-65.
79. Hoimes CJ, Kelly WK. Redefining hormone resistance in prostate cancer. Ther Adv Med Oncol 2010;2(2):107-23.
80. Shen MM, Abate-Shen C. Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev 2010;24(18):1967-2000.
81. Migliaccio A, Castoria G, Di Domenico M, de Falco A, Bilancio A, Lombardi M, et al. Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. EMBO J 2000;19(20):5406-17.
82. Migliaccio A, Varricchio L, De Falco A, Castoria G, Arra C, Yamaguchi H, et al. Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth. Oncogene 2007;26(46):6619-29. (Pubitemid 47573684)
83. Migliaccio A, Castoria G, Di Domenico M, Ciociola A, Lombardi M, De Falco A, et al. Crosstalk between EGFR and extranuclear steroid receptors. Ann NY Acad Sci 2006;1089:194-200. (Pubitemid 47092061)
84. Sen A, O'Malley K, Wang Z, Raj GV, Defranco DB, Hammes SR. Paxillin regulates androgen- and epidermal growth factor-induced MAPK signaling and cell proliferation in prostate cancer cells. J Biol Chem 2010;285(37):28787-95.
85. Pi M, Parrill AL, Quarles LD. GPRC6A mediates the non-genomic effects of steroids. J Biol Chem 2010;285(51):39953-64.
86. Nair SS, Guo Z, Mueller JM, Koochekpour S, Qiu Y, Tekmal RR, et al. Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2. Mol Endocrinol 2007;21(3):613-24.
87. Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, et al. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Cancer Res 2004;64(19):7156-68. (Pubitemid 39331031)
88. Barletta F, Wong CW, McNally C, Komm BS, Katzenellenbogen B, Cheskis BJ. Characterization of the interactions of estrogen receptor and MNAR in the activation of cSrc. Mol Endocrinol 2004;18(5):1096-108. (Pubitemid 38591277)
89. Bennett N, Hooper JD, Lee CS, Gobe GC. Androgen receptor and caveolin-1 in prostate cancer. IUBMB Life 2009;61(10):961-70.
90. Yang G, Addai J, Ittmann M, Wheeler TM, Thompson TC. Elevated caveolin-1 levels in African-American versus white-American prostate cancer. Clin Cancer Res 2000;6(9):3430-3.
91. Mouraviev V, Li L, Tahir SA, Yang G, Timme TM, Goltsov A, et al. The role of caveolin-1 in androgen insensitive prostate cancer. J Urol 2002;168:1589-96 (4 Pt 1).
92. Bonaccorsi L, Nosi D, Quercioli F, Formigli L, Zecchi S, Maggi M, et al. Prostate cancer: a model of integration of genomic and non-genomic effects of the androgen receptor in cell lines model. Steroids 2008;73(9-10):1030-7.
93. Timme TL, Goltsov A, Tahir S, Li L, Wang J, Ren C, et al. Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosis. Oncogene 2000;19(29):3256-65. (Pubitemid 30487412)
94. Li L, Yang G, Ebara S, Satoh T, Nasu Y, Timme TL, et al. Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells. Cancer Res 2001;61(11):4386-92. (Pubitemid 32685764)
95. Vlahopoulos S, Zimmer WE, Jenster G, Belaguli NS, Balk SP, Brinkmann AO, et al. Recruitment of the androgen receptor via serum response factor facilitates expression of a myogenic gene. J Biol Chem 2005;280(9):7786-92. (Pubitemid 40349672)
96. Sinha-Hikim I, Artaza J, Woodhouse L, Gonzalez-Cadavid N, Singh AB, Lee MI, et al. Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy. Am J Physiol Endocrinol Metab 2002;283(1):E154-64.
97. 2+ channels in A7r5 cells by physiological levels of testosterone. Endocrinology 2006;147(6):2675-80.
98. Vicencio JM, Ibarra C, Estrada M, Chiong M, Soto D, Parra V, et al. Testosterone induces an intracellular calcium increase by a nongenomic mechanism in cultured rat cardiac myocytes. Endocrinology 2006;147(3):1386-95. (Pubitemid 43244373)
99. Bai CX, Kurokawa J, Tamagawa M, Nakaya H, Furukawa T. Nontranscriptional regulation of cardiac repolarization currents by testosterone. Circulation 2005;112(12):1701-10. (Pubitemid 41368145)
100. Estrada M, Espinosa A, Muller M, Jaimovich E. Testosterone stimulates intracellular calcium release and mitogen-activated protein kinases via a G protein-coupled receptor in skeletal muscle cells. Endocrinology 2003;144(8):3586-97. (Pubitemid 36904438)
101. Hamdi MM, Mutungi G. Dihydrotestosterone activates the MAPK pathway and modulates maximum isometric force through the EGF receptor in isolated intact mouse skeletal muscle fibres. J Physiol 2010;588(3):511-25.
102. Gonzalez-Montelongo MC, Marin R, Gomez T, Marrero-Alonso J, Diaz M. Androgens induce nongenomic stimulation of colonic contractile activity through induction of calcium sensitization and phosphorylation of LC20 and CPI-17. Mol Endocrinol 2010;24(5):1007-23.
103. Vanderschueren D, Vandenput L, Boonen S, Lindberg MK, Bouillon R, Ohlsson C. Androgens and bone. Endocr Rev 2004;25(3):389-425. (Pubitemid 38786452)
104. Kousteni S, Bellido T, Plotkin LI, O'Brien CA, Bodenner DL, Han L, et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 2001;104(5):719-30. (Pubitemid 32241022)
105. Kousteni S, Chen JR, Bellido T, Han L, Ali AA, O'Brien CA, et al. Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 2002;298(5594):843-6. (Pubitemid 35231540)
106. Almeida M, Han L, Ambrogini E, Bartell SM, Manolagas SC. Oxidative stress stimulates apoptosis and activates NF-kappaB in osteoblastic cells via a PKC-beta/p66shc signaling cascade: counter regulation by estrogens or androgens. Mol Endocrinol 2010;24(10):2030-7.
107. Benten WP, Lieberherr M, Stamm O, Wrehlke C, Guo Z, Wunderlich F. Testosterone signaling through internalizable surface receptors in androgen receptor-free macrophages. Mol Biol Cell 1999;10(10):3113-23. (Pubitemid 29489549)
108. Benten WP, Lieberherr M, Giese G, Wrehlke C, Stamm O, Sekeris CE, et al. Functional testosterone receptors in plasma membranes of T cells. FASEB J 1999;13(1):123-33. (Pubitemid 29038282)
109. Rife SU, Marquez MG, Escalante A, Velich T. The effect of testosterone on the immune response 1. Mechanism of action on antibody-forming cells. Immunol Invest 1990;19(3):259-70.
110. Benten WP, Wunderlich F, Mossmann H. Testosterone-induced suppression of self-healing Plasmodium chabaudi malaria: an effect not mediated by androgen receptors? J Endocrinol 1992;135(3):407-13.
111. Wunderlich F, Benten WP, Lieberherr M, Guo Z, Stamm O, Wrehlke C, et al. Testosterone signaling in T cells and macrophages. Steroids 2002;67(6):535-8. (Pubitemid 34311771)
112. Guo Z, Benten WP, Krucken J, Wunderlich F. Nongenomic testosterone calcium signaling. Genotropic actions in androgen receptor-free macrophages. J Biol Chem 2002;277(33):29600-7. (Pubitemid 41079249)
113. 2+ influx via non-genomic surface receptors in activated T cells. FEBS Lett 1997;407(2):211-4.
114. 2+ influx in bone marrow-derived macrophages via surface binding sites. Methods Find Exp Clin Pharmacol 2005;27(9):623-8.